“The British drug company GlaxoSmithKline said Thursday that it has agreed to pay $3 billion to settle United States government civil and criminal investigations into its sales practices. The settlement is the largest yet in a wave of cases brought against pharmaceutical companies for illegal marketing of drugs, passing the previous record of $2.3 billion paid by Pfizer in 2009. In recent years, drug companies have been the major targets of federal fraud investigations that cost Medicare and Medicaid tens of billions of dollars.” Read the rest of the story here.
Advertisements
